StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.11+0.10 (+0.30%)

Close on Nov 18, 2026Market cap $1.93BP/E 10.7Yield –

Harmony Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Harmony Biosciences's market cap was $1.99B on Nov 11, 2026, against $2.03B a year earlier. Over the last 5 years it ranged from $1.41B to $3.54B, with a median of $2.04B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.99B-7.7%
2025Dec 31, 2025$2.16B+9.8%
2024Dec 31, 2024$1.96B+3.7%
2023Dec 29, 2023$1.89B-42.1%
2022Dec 30, 2022$3.27B+31.2%
2021Dec 31, 2021$2.49B+21.1%
2020Dec 31, 2020$2.06B–

More Harmony Biosciences figures

See a number that looks wrong?